ICCC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmuCell Corp

Watchlist Manager

Watchlist

Price: 10 USD Market Closed

Market Cap: $90.5m

	ImmuCell Corp NASDAQ:ICCC	US

Profitability Summary

ImmuCell Corp's profitability score is 47/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Sustainable 3Y Average Gross Margin

33%

Gross Margin is Increasing

27% > 40%

Low Operating Margin

Negative 3Y Average Operating Margin

-9%

Operating Margin is Increasing

-37% > 4%

Low Net Margin

Negative 3Y Average Net Margin

-10%

Net Margin is Increasing

-38% > 3%

Exceptional Free Cash Flow Margin

14%

Negative 3Y Average Free Cash Flow Margin

-6%

Free Cash Flow Margin is Increasing

-61% > 14%

Low ROE

Negative 3Y Average ROE

Negative 3Y Average ROIC

-4%

ROIC is Increasing

-15% > 3%

View All

Hide

Collapse

47 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.